Dr Rory Chan

Clinical Senior Lecturer Hon Consultant

Respiratory Medicine and Gastroenterology, School of Medicine

On this page



As a clinical academic with expertise in respiratory and general internal medicine, a significant component of Rory’s work relates to both person-centric research, as well as inpatient and outpatient clinical care to fully appreciate the translational nature of his research.

Rory has excellent collaborative relationships with several international pharmaceutical companies and has attracted £1m in grant funding as a co-investigator in the past few years. Additionally, he is an Editorial Board Member in Asthma for the international journal CHEST. 


  1. Prospective clinical trial demonstrating, for the first time, efficacy of anti-IL5Rα therapy in attenuating mannitol airway hyperresponsiveness in patients with severe eosinophilic asthma. (Chan R et al. J Allergy Clin Immunol. 2023 Mar;151(3):700-705.e10.)
  2. Health informatics database showed that combining two pulmonary function tests as spirometry and airway oscillometry better identifies people with persistent asthma who have a higher risk of poor symptom control and severe exacerbations. (Chan R et al. Eur Respir J. 2022 Oct 13;60(4):2200543.)
  3. A multidisciplinary team-based approach with thoracic radiologists revealed a close relationship between key asthma outcomes and mediastinal lymph node size (Chan R et al. Am J Respir Crit Care Med. 2024 Feb 1;209(3):331-334.), mucus plugging (Chan R et al. J Allergy Clin Immunol Pract. 2023 Jan;11(1):195-199.e2.) and bronchial wall thickening (Chan R et al. J Allergy Clin Immunol Pract. 2023 May;11(5):1459-1462.e3.)